Publicaciones científicas

4 Publicaciones científicas disponibles

  • Diverse Immune Environments in Human Lung Tuberculosis Granulomas Assessed by Quantitative Multiplexed Immunofluorescence

    26 de junio de 2020 | Revista: Modern Pathology

    Marta Abengozar-Muela (1), María Villalba Esparza (1, 2, 3), David Garcia-Ros (1, 2, 4), Cindy Estefanía Vásquez (4), José I Echeveste (1, 2) , Miguel Angel Idoate (1, 2), Maria D Lozano (1, 2, 3), Ignacio Melero (2, 3, 5, 6), Carlos E de Andrea  (7, 8, 9, 10)

    (1) Department of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
    (2) Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
    (3) Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
    (4) Department of Anatomy, Physiology and Pathology, University of Navarra, Pamplona, Spain.
    (5) Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.
    (6) Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
    (7) Department of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
    (8) Navarra Institute for Health Research (IDISNA), Pamplona, Spain. 
    (9) Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
    (10) Department of Anatomy, Physiology and Pathology, University of Navarra, Pamplona, Spain.


  • Cutis verticis gyrata primario no esencial pruriginoso

    11 de marzo de 2019 | Revista: Actas Dermo-sifiliográficas

    Tomás-Velázquez A (1), Moreno-Artero E (2), Abengózar M (3), Palacios-Álvarez I (2)

    (1) Departamento de Dermatología Médico-Quirúrgica y Venereología, Clínica Universidad de Navarra, Pamplona, Navarra, España.
    (2) Departamento de Dermatología Médico-Quirúrgica y Venereología, Clínica Universidad de Navarra, Pamplona, Navarra, España.
    (3= Departamento de Anatomía Patológica, Clínica Universidad de Navarra, Pamplona, Navarra, España.


  • Identification of mutations associated with acquired resistance to sunitinib in renal cell-cancer

    8 de marzo de 2019 | Revista: International Journal of Cancer

    Elgendy M (1,2), Fusco JP (3,4), Segura V (5), Lozano MD (4,6,7), Minucci S (1,8), Echeveste JI (4,6), Gurpide A (3,4), Andueza M (3,4), Melero I (4,7,9), Sanmamed MF (3,4), Ruiz MR (3,4), Calvo A (4,10), Pascual JI (4,11), Velis JM (4,11), Miñana B (4,11), Valle RD (4,12), Pio R (4,7,13), Agorreta J (4,7,13), Abengozar M (4,6), Colecchia M (14), Brich S (14), Renne SL (14), Guruceaga E (5), Patiño-García A (4,13,15), Perez-Gracia JL (3,4,7).

    (1) Department of Experimental Oncology, European Institute of Oncology (IEO), Milan, Italy.
    (2) Department of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
    (3) Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain.
    (4) Health Research Institute of Navarra (IDISNA), Pamplona, Spain.
    (5) IDISNA and Bioinformatics Unit, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain.
    (6) Pathology Department, Clinica Universidad de Navarra, Pamplona, Spain.
    (7) Centro de Investigación Biomédica en Red de Cáncer (CIBERONC).
    (8) Department of Biosciences, University of Milan, Milan, Italy.
    (9) Department of Immunology, Center for Applied Medical Research (CIMA), Pamplona, Spain.
    (10) Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Navarra, Spain.
    (11) Department of Urology, Clinica Universidad de Navarra, Pamplona and Madrid, Spain.
    (12) Department of Neurosurgery, University Clinic of Navarra, Pamplona, Spain.
    (13) Program in Solid Tumors. Center for Applied Medical Research (CIMA), Pamplona, Spain.
    (14) Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
    (15) Department of Pediatrics and Clinical Genetics, Clinica Universidad de Navarra, Pamplona, Spain.


  • Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer

    1 de marzo de 2018 | Revista: Archives of Pathology & Laboratory Medicine

    Lozano MDEcheveste JIAbengozar M, Mejías LD, Idoate MA, Calvo A, de Andrea CE (1).

    (1) From the Department of Pathology, Clínica Universidad de Navarra, (Drs Lozano, Echeveste, Abengozar, Mejías, Idoate, and de Andrea), IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA) (Dr Calvo), and the Department of Histology and Pathology (Drs Calvo and de Andrea), University of Navarra, Pamplona, Spain.